Correlation Between Centessa Pharmaceuticals and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and InMed Pharmaceuticals, you can compare the effects of market volatilities on Centessa Pharmaceuticals and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and InMed Pharmaceuticals.
Diversification Opportunities for Centessa Pharmaceuticals and InMed Pharmaceuticals
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Centessa and InMed is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and InMed Pharmaceuticals
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.32 times more return on investment than InMed Pharmaceuticals. However, Centessa Pharmaceuticals PLC is 3.17 times less risky than InMed Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 645.00 in Centessa Pharmaceuticals PLC on September 4, 2024 and sell it today you would earn a total of 1,067 from holding Centessa Pharmaceuticals PLC or generate 165.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. InMed Pharmaceuticals
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| InMed Pharmaceuticals |
Centessa Pharmaceuticals and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and InMed Pharmaceuticals
The main advantage of trading using opposite Centessa Pharmaceuticals and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.The idea behind Centessa Pharmaceuticals PLC and InMed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |